Journal of the National Comprehensive Cancer Network · 2014 · 333 citations · 0 references
MedicineOncologyUrologyGenitourinary OncologySurgical OncologyUrologic OncologyActive SurveillanceCancer Treatment PlanningProstate CancerProstate Cancer ImagingProstate ImagingRadiation TherapyActive Surveillance AssessmentAdvanced Prostate Cancer TherapyClinical Guideline Evidence ReviewConsensusEarly Disease DetectionLocalized Disease AssessmentStaging Of Advanced DiseaseStaging Of Localized Disease
Prostate cancer has surpassed lung cancer as the most common cancer in men in the United States. The NCCN Guidelines for Prostate Cancer provide multidisciplinary recommendations on the clinical management of patients with prostate cancer based on clinical evidence and expert consensus. NCCN Panel guidance on treatment decisions for patients with localized disease is represented in this version. Significant updates for early disease include distinction between active surveillance and observation, a new section on principles of imaging, and revisions to radiation recommendations. The full version of these guidelines, including treatment of patients with advanced disease, can be found online at the NCCN website.